Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 110

1.

Detection and management of atypical femur fractures.

Divan V, Rao SD, Dhaliwal R.

Curr Opin Endocrinol Diabetes Obes. 2019 Oct 5. doi: 10.1097/MED.0000000000000505. [Epub ahead of print]

PMID:
31592780
2.

Dysregulated mitogen-activated protein kinase pathway mediated cell cycle disruption in sporadic parathyroid tumors.

Arya AK, Singh P, Saikia UN, Sachdeva N, Dahiya D, Behera A, Rao SD, Bhadada SK.

J Endocrinol Invest. 2019 Sep 18. doi: 10.1007/s40618-019-01098-3. [Epub ahead of print]

PMID:
31535356
3.

DPP9's Enzymatic Activity and Not Its Binding to CARD8 Inhibits Inflammasome Activation.

Griswold AR, Ball DP, Bhattacharjee A, Chui AJ, Rao SD, Taabazuing CY, Bachovchin DA.

ACS Chem Biol. 2019 Sep 20. doi: 10.1021/acschembio.9b00462. [Epub ahead of print]

PMID:
31525884
4.

The Hyperechoic Appearance of the Deltoid Muscle on Shoulder Ultrasound Imaging as a Predictor of Diabetes and Prediabetes.

Soliman SB, Rosen KA, Williams PC, Spicer PJ, Williams LK, Rao SD, van Holsbeeck MT.

J Ultrasound Med. 2019 Aug 18. doi: 10.1002/jum.15110. [Epub ahead of print]

PMID:
31423604
5.

DPP8/9 inhibitors are universal activators of functional NLRP1 alleles.

Gai K, Okondo MC, Rao SD, Chui AJ, Ball DP, Johnson DC, Bachovchin DA.

Cell Death Dis. 2019 Aug 5;10(8):587. doi: 10.1038/s41419-019-1817-5.

6.

Pulmonary Hypertension in Advanced Heart Failure: Assessment and Management of the Failing RV and LV.

Rao SD, Menachem JN, Birati EY, Mazurek JA.

Curr Heart Fail Rep. 2019 Jul 10. doi: 10.1007/s11897-019-00431-4. [Epub ahead of print] Review.

PMID:
31292856
7.

The relative influence of serum ionized calcium and 25-hydroxyvitamin D in regulating PTH secretion in healthy subjects.

Ferrone F, Pepe J, Danese VC, Fassino V, Cecchetti V, De Lucia F, Biamonte F, Colangelo L, Ferrazza G, Panzini E, Scillitani A, Nieddu L, Blocki F, Rao SD, Minisola S, Cipriani C.

Bone. 2019 Aug;125:200-206. doi: 10.1016/j.bone.2019.05.029. Epub 2019 May 23.

PMID:
31129357
8.

Fibrogenesis Imperfecta Ossium.

Bhadada SK, Dhaliwal R, Dhiman V, Rao SD.

Calcif Tissue Int. 2019 May;104(5):561-569. doi: 10.1007/s00223-019-00547-8. Epub 2019 May 8. Review.

PMID:
31069441
9.

A Chemical Strategy for Protease Substrate Profiling.

Griswold AR, Cifani P, Rao SD, Axelrod AJ, Miele MM, Hendrickson RC, Kentsis A, Bachovchin DA.

Cell Chem Biol. 2019 Jun 20;26(6):901-907.e6. doi: 10.1016/j.chembiol.2019.03.007. Epub 2019 Apr 18.

PMID:
31006619
10.

N-terminal degradation activates the NLRP1B inflammasome.

Chui AJ, Okondo MC, Rao SD, Gai K, Griswold AR, Johnson DC, Ball DP, Taabazuing CY, Orth EL, Vittimberga BA, Bachovchin DA.

Science. 2019 Apr 5;364(6435):82-85. doi: 10.1126/science.aau1208. Epub 2019 Mar 14.

PMID:
30872531
11.

Fibrogenesis Imperfecta Ossium: Clinical Approach to Diagnosis and Management of a Rare Skeletal Disorder.

Dhaliwal R, Dhiman V, Rao SD, Bhadada SK.

J Clin Endocrinol Metab. 2019 Mar 14. pii: jc.2018-01180. doi: 10.1210/jc.2018-01180. [Epub ahead of print]

PMID:
30869792
12.

Epidemiology of parathyroid disorders.

Rao SD.

Best Pract Res Clin Endocrinol Metab. 2018 Dec;32(6):773-780. doi: 10.1016/j.beem.2018.12.003. Epub 2018 Dec 7. Review.

PMID:
30559041
13.

Quantitative proteomics analysis of sporadic parathyroid adenoma tissue samples.

Arya AK, Bhadada SK, Singh P, Dahiya D, Kaur G, Sharma S, Saikia UN, Behera A, Rao SD, Bhasin M.

J Endocrinol Invest. 2019 May;42(5):577-590. doi: 10.1007/s40618-018-0958-1. Epub 2018 Oct 3.

PMID:
30284223
14.

DPP8/DPP9 inhibitor-induced pyroptosis for treatment of acute myeloid leukemia.

Johnson DC, Taabazuing CY, Okondo MC, Chui AJ, Rao SD, Brown FC, Reed C, Peguero E, de Stanchina E, Kentsis A, Bachovchin DA.

Nat Med. 2018 Aug;24(8):1151-1156. doi: 10.1038/s41591-018-0082-y. Epub 2018 Jul 2.

15.

Bone histomorphometry in the evaluation of osteomalacia.

Bhan A, Qiu S, Rao SD.

Bone Rep. 2018 Mar 17;8:125-134. doi: 10.1016/j.bonr.2018.03.005. eCollection 2018 Jun.

16.

Progression of Mineral Ion Abnormalities in Patients With Jansen Metaphyseal Chondrodysplasia.

Saito H, Noda H, Gatault P, Bockenhauer D, Loke KY, Hiort O, Silve C, Sharwood E, Martin RM, Dillon MJ, Gillis D, Harris M, Rao SD, Pauli RM, Gardella TJ, Jüppner H.

J Clin Endocrinol Metab. 2018 Jul 1;103(7):2660-2669. doi: 10.1210/jc.2018-00332.

17.

Trueness, precision and stability of the LIAISON 1-84 parathyroid hormone (PTH) third-generation assay: comparison to existing intact PTH assays.

Valcour A, Zierold C, Blocki FA, Hawkins DM, Martin KJ, Rao SD, Bonelli F.

Clin Chem Lab Med. 2018 Aug 28;56(9):1476-1482. doi: 10.1515/cclm-2018-0217.

18.

Inhibition of Dpp8/9 Activates the Nlrp1b Inflammasome.

Okondo MC, Rao SD, Taabazuing CY, Chui AJ, Poplawski SE, Johnson DC, Bachovchin DA.

Cell Chem Biol. 2018 Mar 15;25(3):262-267.e5. doi: 10.1016/j.chembiol.2017.12.013. Epub 2018 Jan 27.

19.

Multiple Vertebral Osteonecroses (Kṻmmell's Disease) After 10 Years on Denosumab: Is Osteocyte Apoptosis to Blame? More Evidence Needed.

Biamonte F, Rao SD, Cipriani C, Pepe J, Biondi P, Minisola S.

Calcif Tissue Int. 2018 Jul;103(1):109-110. doi: 10.1007/s00223-017-0386-9. Epub 2018 Jan 9. No abstract available.

PMID:
29318330
20.

Functional Outcomes After De-escalated Chemoradiation Therapy for Human Papillomavirus-Positive Oropharyngeal Cancer: Secondary Analysis of a Phase 2 Trial.

Hegde JV, Shaverdian N, Felix C, Wang PC, Veruttipong D, Hsu S, Riess JW, Rao SD, Daly ME, Chen AM.

Int J Radiat Oncol Biol Phys. 2018 Mar 1;100(3):647-651. doi: 10.1016/j.ijrobp.2017.10.045. Epub 2017 Nov 6.

PMID:
29246721
21.

A Randomized, Double Blind, Placebo Controlled, Crossover Study to Assess the Safety and Beneficial Effects of Cassia Tora Supplementation in Healthy Adults.

Kambalachenu HR, Reddy TM, Rao SD, Dorababu K, Reddy KK, Sarma KVS.

Rev Recent Clin Trials. 2018 Jan 31;13(1):69-78. doi: 10.2174/1574887112666171120094539.

PMID:
29165093
22.

Remodeling- and Modeling-Based Bone Formation With Teriparatide Versus Denosumab: A Longitudinal Analysis From Baseline to 3 Months in the AVA Study.

Dempster DW, Zhou H, Recker RR, Brown JP, Recknor CP, Lewiecki EM, Miller PD, Rao SD, Kendler DL, Lindsay R, Krege JH, Alam J, Taylor KA, Melby TE, Ruff VA.

J Bone Miner Res. 2018 Feb;33(2):298-306. doi: 10.1002/jbmr.3309. Epub 2017 Nov 15.

23.

Comparative Effectiveness of Ultrasonography, 99mTc-Sestamibi, and 18F-Fluorocholine PET/CT in Detecting Parathyroid Adenomas in Patients With Primary Hyperparathyroidism.

Thanseer N, Bhadada SK, Sood A, Mittal BR, Behera A, Gorla AKR, Kalathoorakathu RR, Singh P, Dahiya D, Saikia UN, Rao SD.

Clin Nucl Med. 2017 Dec;42(12):e491-e497. doi: 10.1097/RLU.0000000000001845.

PMID:
28902729
24.

PREVALENCE AND PREDICTORS OF PRIMARY HYPERPARATHYROIDISM AMONG PATIENTS WITH UROLITHIASIS.

Sharma S, Rastogi A, Bhadada SK, Singh P, Varshney S, Behera A, Bhansali A, Singh SK, Rao SD.

Endocr Pract. 2017 Nov;23(11):1311-1315. doi: 10.4158/EP171759.OR. Epub 2017 Aug 17.

PMID:
28816531
25.

Prospective radiotherapy for patients with oropharyngeal carcinoma - Authors' reply.

Chen AM, Beron PJ, Wong D, Rosove MH, Rao SD, Steinberg ML, Kupelian PA, Daly ME.

Lancet Oncol. 2017 Aug;18(8):e426. doi: 10.1016/S1470-2045(17)30534-X. Epub 2017 Jul 26. No abstract available.

PMID:
28759373
26.

Effect of Antidepressant Switching vs Augmentation on Remission Among Patients With Major Depressive Disorder Unresponsive to Antidepressant Treatment: The VAST-D Randomized Clinical Trial.

Mohamed S, Johnson GR, Chen P, Hicks PB, Davis LL, Yoon J, Gleason TC, Vertrees JE, Weingart K, Tal I, Scrymgeour A, Lawrence DD, Planeta B, Thase ME, Huang GD, Zisook S; and the VAST-D Investigators, Rao SD, Pilkinton PD, Wilcox JA, Iranmanesh A, Sapra M, Jurjus G, Michalets JP, Aslam M, Beresford T, Anderson KD, Fernando R, Ramaswamy S, Kasckow J, Westermeyer J, Yoon G, D'Souza DC, Larson G, Anderson WG, Klatt M, Fareed A, Thompson SI, Carrera CJ, Williams SS, Juergens TM, Albers LJ, Nasdahl CS, Villarreal G, Winston JL, Nogues CA, Connolly KR, Tapp A, Jones KA, Khatkhate G, Marri S, Suppes T, LaMotte J, Hurley R, Mayeda AR, Niculescu AB 3rd, Fischer BA, Loreck DJ, Rosenlicht N, Lieske S, Finkel MS, Little JT.

JAMA. 2017 Jul 11;318(2):132-145. doi: 10.1001/jama.2017.8036.

27.

Promoter hypermethylation inactivates CDKN2A, CDKN2B and RASSF1A genes in sporadic parathyroid adenomas.

Arya AK, Bhadada SK, Singh P, Sachdeva N, Saikia UN, Dahiya D, Behera A, Bhansali A, Rao SD.

Sci Rep. 2017 Jun 9;7(1):3123. doi: 10.1038/s41598-017-03143-8.

28.

Letter to the Editor: Severe Rebound-Associated Vertebral Fractures After Denosumab Discontinuation.

Rao SD, Qiu S, Dhaliwal R, Bhadada SK.

J Clin Endocrinol Metab. 2017 Jun 1;102(6):2111. doi: 10.1210/jc.2016-4037. No abstract available.

PMID:
28586451
29.

Fibrogenesis Imperfecta Ossium and Response to Human Growth Hormone: A Potential Therapy.

Bhadada SK, Dhiman V, Mukherjee S, Aggarwal S, Bal A, Sukumar SP, Sood A, Sharma DC, Khandelwal N, Bhansali A, Van Hul W, Rao SD.

J Clin Endocrinol Metab. 2017 May 1;102(5):1750-1756. doi: 10.1210/jc.2016-3055.

PMID:
28323922
30.

ANABOLIC BONE WINDOW WITH WEEKLY TERIPARATIDE THERAPY IN POSTMENOPAUSAL OSTEOPOROSIS: A PILOT STUDY.

Gopalaswamy V, Dhibar DP, Gupta V, Arya AK, Khandelwal N, Bhansali A, Garg SK, Agarwal N, Rao SD, Bhadada SK.

Endocr Pract. 2017 Jun;23(6):657-661. doi: 10.4158/EP161394.OR. Epub 2017 Feb 22.

PMID:
28225309
31.

Bone Structure and Turnover Status in Postmenopausal Women with Atypical Femur Fracture After Prolonged Bisphosphonate Therapy.

Qiu S, Divine GW, Palnitkar S, Kulkarni P, Guthrie TS, Honasoge M, Rao SD.

Calcif Tissue Int. 2017 Mar;100(3):235-243. doi: 10.1007/s00223-016-0223-6. Epub 2016 Dec 24.

32.

Effect of curative parathyroidectomy on insulin resistance.

Putnam R, Dhibar DP, Varshney S, Behera A, Mittal BR, Bhansali A, Rao SD, Bhadada SK.

Indian J Endocrinol Metab. 2016 Nov-Dec;20(6):784-789.

33.

Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus.

Khan AA, Hanley DA, Rizzoli R, Bollerslev J, Young JE, Rejnmark L, Thakker R, D'Amour P, Paul T, Van Uum S, Shrayyef MZ, Goltzman D, Kaiser S, Cusano NE, Bouillon R, Mosekilde L, Kung AW, Rao SD, Bhadada SK, Clarke BL, Liu J, Duh Q, Lewiecki EM, Bandeira F, Eastell R, Marcocci C, Silverberg SJ, Udelsman R, Davison KS, Potts JT Jr, Brandi ML, Bilezikian JP.

Osteoporos Int. 2017 Jan;28(1):1-19. doi: 10.1007/s00198-016-3716-2. Epub 2016 Sep 9. Review.

34.

Erratum to: The advantages of tomosynthesis for evaluating bisphosphonate-related atypical femur fractures compared to radiography.

Petraszko A, Siegal D, Flynn M, Rao SD, Peterson E, van Holsbeeck M.

Skeletal Radiol. 2016 May;45(5):625. doi: 10.1007/s00256-016-2355-1. No abstract available.

PMID:
26899141
35.

The advantages of tomosynthesis for evaluating bisphosphonate-related atypical femur fractures compared to radiography.

Petraszko A, Siegal D, Flynn M, Rao SD, Peterson E, van Holsbeeck M.

Skeletal Radiol. 2016 May;45(5):615-23. doi: 10.1007/s00256-016-2342-6. Epub 2016 Feb 10. Erratum in: Skeletal Radiol. 2016 May;45(5):625.

PMID:
26861160
36.

Differential Effects of Teriparatide and Denosumab on Intact PTH and Bone Formation Indices: AVA Osteoporosis Study.

Dempster DW, Zhou H, Recker RR, Brown JP, Recknor CP, Lewiecki EM, Miller PD, Rao SD, Kendler DL, Lindsay R, Krege JH, Alam J, Taylor KA, Janos B, Ruff VA.

J Clin Endocrinol Metab. 2016 Apr;101(4):1353-63. doi: 10.1210/jc.2015-4181. Epub 2016 Feb 9.

37.

A Longitudinal Study of Skeletal Histomorphometry at 6 and 24 Months Across Four Bone Envelopes in Postmenopausal Women With Osteoporosis Receiving Teriparatide or Zoledronic Acid in the SHOTZ Trial.

Dempster DW, Zhou H, Recker RR, Brown JP, Bolognese MA, Recknor CP, Kendler DL, Lewiecki EM, Hanley DA, Rao SD, Miller PD, Woodson GC 3rd, Lindsay R, Binkley N, Alam J, Ruff VA, Gallagher ER, Taylor KA.

J Bone Miner Res. 2016 Jul;31(7):1429-39. doi: 10.1002/jbmr.2804. Epub 2016 Mar 8.

38.

Letter to the Editor: Effect of Parathyroidectomy on Renal Function: Dichotomous Results and Confusing Conclusions.

Kulkarni P, Lahiri SW, Rao SD.

J Clin Endocrinol Metab. 2016 Feb;101(2):L9. doi: 10.1210/jc.2015-3936. No abstract available.

PMID:
26840121
39.

Plasmid-derived DNA Strand Displacement Gates for Implementing Chemical Reaction Networks.

Chen YJ, Rao SD, Seelig G.

J Vis Exp. 2015 Nov 25;(105). doi: 10.3791/53087.

40.

Factors influencing the efficacy of rilpivirine in HIV-1 subtype C in low- and middle-income countries.

Neogi U, Häggblom A, Singh K, Rogers LC, Rao SD, Amogne W, Schülter E, Zazzi M, Arnold E, Sarafianos SG, Sönnerborg A.

J Antimicrob Chemother. 2016 Feb;71(2):367-71. doi: 10.1093/jac/dkv359. Epub 2015 Oct 30.

41.

Incidence and predictors of myocardial recovery on long-term left ventricular assist device support: Results from the United Network for Organ Sharing database.

Pan S, Aksut B, Wever-Pinzon OE, Rao SD, Levin AP, Garan AR, Fried JA, Takeda K, Hiroo T, Yuzefpolskaya M, Uriel N, Jorde UP, Mancini DM, Naka Y, Colombo PC, Topkara VK.

J Heart Lung Transplant. 2015 Dec;34(12):1624-9. doi: 10.1016/j.healun.2015.08.004. Epub 2015 Sep 1.

PMID:
26442678
42.

Dose-volume factors correlating with trismus following chemoradiation for head and neck cancer.

Rao SD, Saleh ZH, Setton J, Tam M, McBride SM, Riaz N, Deasy JO, Lee NY.

Acta Oncol. 2016;55(1):99-104. doi: 10.3109/0284186X.2015.1037864. Epub 2015 Apr 29.

43.

A clinical trial for evaluation of leech application in the management of Vicarcikā (Eczema).

Shankar KM, Rao SD, Umar SN, Gopalakrishnaiah V.

Anc Sci Life. 2014 Apr-Jun;33(4):236-41. doi: 10.4103/0257-7941.147432.

44.

Early pregnancy vitamin D and patterns of antenatal inflammation in African-American women.

Bobbitt KR, Peters RM, Li J, Rao SD, Woodcroft KJ, Cassidy-Bushrow AE.

J Reprod Immunol. 2015 Feb;107:52-8. doi: 10.1016/j.jri.2014.09.054. Epub 2014 Oct 14.

PMID:
25453750
45.

Genetic factors associated with slow progression of HIV among perinatally-infected Indian children.

Chaudhuri RP, Neogi U, Rao SD, Shet A.

Indian Pediatr. 2014 Oct;51(10):801-3.

46.

Sclerostin: recent advances and clinical implications.

Honasoge M, Rao AD, Rao SD.

Curr Opin Endocrinol Diabetes Obes. 2014 Dec;21(6):437-46. doi: 10.1097/MED.0000000000000114. Review.

PMID:
25333305
47.

Novel tetra-peptide insertion in Gag-p6 ALIX-binding motif in HIV-1 subtype C associated with protease inhibitor failure in Indian patients.

Neogi U, Rao SD, Bontell I, Verheyen J, Rao VR, Gore SC, Soni N, Shet A, Schülter E, Ekstrand ML, Wondwossen A, Kaiser R, Madhusudhan MS, Prasad VR, Sonnerborg A.

AIDS. 2014 Sep 24;28(15):2319-22. doi: 10.1097/QAD.0000000000000419.

48.

Cost-efficient HIV-1 drug resistance surveillance using multiplexed high-throughput amplicon sequencing: implications for use in low- and middle-income countries.

Ekici H, Rao SD, Sönnerborg A, Ramprasad VL, Gupta R, Neogi U.

J Antimicrob Chemother. 2014 Dec;69(12):3349-55. doi: 10.1093/jac/dku278. Epub 2014 Jul 31.

PMID:
25085657
49.

A nomogram to predict loco-regional control after re-irradiation for head and neck cancer.

Riaz N, Hong JC, Sherman EJ, Morris L, Fury M, Ganly I, Wang TJ, Shi W, Wolden SL, Jackson A, Wong RJ, Zhang Z, Rao SD, Lee NY.

Radiother Oncol. 2014 Jun;111(3):382-7. doi: 10.1016/j.radonc.2014.06.003. Epub 2014 Jun 30.

50.

Changes in parathyroid proteome in patients with primary hyperparathyroidism due to sporadic parathyroid adenomas.

Varshney S, Bhadada SK, Arya AK, Sharma S, Behera A, Bhansali A, Rao SD.

Clin Endocrinol (Oxf). 2014 Oct;81(4):614-20. doi: 10.1111/cen.12479. Epub 2014 Jun 5.

PMID:
24766412

Supplemental Content

Support Center